Therapeutic Asset Ratings
383 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Calaspargase Pegol
Acute Myeloid Leukemia
Children's Oncology Group
P2
CCC
(50)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Acute Myeloid Leukemia
Children's Oncology Group
P2
CCC
(50)
VINCRISTINE SULFATE
Acute Myeloid Leukemia
Children's Oncology Group
P2
CCC
(50)
Lapine T-Lymphocyte Immune Globulin
Mixed Phenotype Acute Leukemia
Children's Oncology Group
P3
CCC
(48)
Lapine T-Lymphocyte Immune Globulin
Myelodysplastic Syndrome
Children's Oncology Group
P3
CCC
(48)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Cpx-351
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Cpx-351
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
dt2216
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology Group
P1/2
CCC
(48)
dt2216
Recurrent Childhood Malignant Solid Neoplasm
Children's Oncology Group
P1/2
CCC
(48)
dt2216
Refractory Childhood Malignant Solid Neoplasm
Children's Oncology Group
P1/2
CCC
(48)
Fludarabine
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Imgn632
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Imgn632
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Irinotecan
Recurrent Childhood Malignant Solid Neoplasm
Children's Oncology Group
P1/2
CCC
(48)
Irinotecan
Refractory Childhood Malignant Solid Neoplasm
Children's Oncology Group
P1/2
CCC
(48)
METHOTREXATE
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Solu-Cortef
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Tegavivint
Endometrial Carcinoma
Children's Oncology Group
P1/2
CCC
(48)
Tegavivint
Desmoid Tumor
Children's Oncology Group
P1/2
CCC
(48)
Tegavivint
Ewing Sarcoma
Children's Oncology Group
P1/2
CCC
(48)
Tegavivint
Hepatoblastoma
Children's Oncology Group
P1/2
CCC
(48)
Tegavivint
Non-Hodgkin Lymphoma
Children's Oncology Group
P1/2
CCC
(48)
Tegavivint
Osteosarcoma
Children's Oncology Group
P1/2
CCC
(48)
Tegavivint
Solid Pseudopapillary Neoplasm Of The Pancreas
Children's Oncology Group
P1/2
CCC
(48)
Showing 301 to 325 of 383 assets
Previous
Page 13 of 16
Next